We are live on
!
Find out more
SG Americas Securities Portfolio holdings
AUM
$92.9B
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
-6.3%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$30.5B
AUM Growth
+$6.11B
(+25%)
Cap. Flow
+$9.67B
Cap. Flow
% of AUM
31.72%
Top 10 Holdings %
Top 10 Hldgs %
46.6%
Holding
3,856
New
751
Increased
1,330
Reduced
1,206
Closed
418
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$507M |
| 3 |
NVIDIA
NVDA
|
+$470M |
| 4 |
Meta Platforms (Facebook)
META
|
+$404M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
Oracle
ORCL
|
+$111M |
| 4 |
Microsoft
MSFT
|
+$109M |
| 5 |
Intuit
INTU
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Communication Services | 17.72% |
| 3 | Healthcare | 7.71% |
| 4 | Financials | 7.66% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Future Fuel
FF
$216M
| $40K | ﹤0.01% |
10,351
-2,639
| -20% | -$12.7K |
|
3202
Genelux
GNLX
$126M
| $40K | ﹤0.01% |
+14,690
| New | +$55.1K |
|
3203
Genasys
GNSS
$79.2M
| $40K | ﹤0.01% |
+17,773
| New | +$49.3K |
|
3204
InnovAge Holding
INNV
$1.47B
| $40K | ﹤0.01% |
13,579
+2,652
| +24% | +$9.15K |
|
3205
Ironwood Pharmaceuticals
IRWD
$709M
| $40K | ﹤0.01% |
27,118
+15,249
| +128% | +$36.3K |
|
3206
Nektar Therapeutics
NKTR
$2.46B
| $40K | ﹤0.01% |
3,913
-3,242
| -45% | -$42.4K |
|
3207
Clarus
CLAR
$129M
| $39K | ﹤0.01% |
10,527
-2,320
| -18% | -$10.4K |
|
3208
GoPro
GPRO
$133M
| $39K | ﹤0.01% |
58,208
-69,115
| -54% | -$61K |
|
3209
Lyell Immunopharma
LYEL
$333M
| $39K | ﹤0.01% |
3,594
-2,243
| -38% | -$27.5K |
|
3210
CALL
NXP Semiconductors
NXPI
$59.9B
| $39K | ﹤0.01% |
15,700
-12,500
| -44% | -$2.67M |
|
3211
Pacific Biosciences
PACB
$447M
| $39K | ﹤0.01% |
32,904
+19,203
| +140% | +$29.5K |
|
3212
AtaiBeckley Inc
ATAI
$2.66B
| $38K | ﹤0.01% |
27,623
-23,915
| -46% | -$40.2K |
|
|
SLI
3213
Standard Lithium
SLI
$544M
| $38K | ﹤0.01% |
30,069
+83
| +0.3% | +$120 |
|
|
VIGL
3214
DELISTED
Vigil Neuroscience
VIGL
| $38K | ﹤0.01% |
+21,417
| New | +$48.1K |
|
3215
Zentalis Pharmaceuticals
ZNTL
$347M
| $38K | ﹤0.01% |
24,104
-32,285
| -57% | -$69.6K |
|
3216
Editas Medicine
EDIT
$425M
| $37K | ﹤0.01% |
31,516
-50,153
| -61% | -$73.8K |
|
3217
Paysign
PAYS
$519M
| $37K | ﹤0.01% |
17,510
+2,002
| +13% | +$5.34K |
|
|
THRD
3218
DELISTED
Third Harmonic Bio
THRD
| $37K | ﹤0.01% |
10,574
-1,476
| -12% | -$7.16K |
|
|
RPT
3219
Rithm Property Trust
RPT
$93.4M
| $37K | ﹤0.01% |
+2,154
| New | +$39K |
|
3220
CALL
Scotiabank
BNS
$106B
| $36K | ﹤0.01% |
+20,600
| New | +$1.03M |
|
3221
CALL
Pultegroup
PHM
$25.1B
| $36K | ﹤0.01% |
16,000
-2,100
| -12% | -$227K |
|
|
SCPH
3222
DELISTED
scPharmaceuticals
SCPH
| $36K | ﹤0.01% |
13,761
-4,797
| -26% | -$15.6K |
|
3223
Senseonics Holdings Inc
SENS
$282M
| $36K | ﹤0.01% |
+2,774
| New | +$45.8K |
|
3224
PUT
State Street
STT
$50.9B
| $36K | ﹤0.01% |
47,500
| – | – |
|
3225
AbCellera Biologics
ABCL
$1.86B
| $35K | ﹤0.01% |
+15,577
| New | +$44.7K |
|
Similar funds
SG Americas Securities's Q1 2025 Portfolio in Review
As of Q1 2025, SG Americas Securities held 3,856 positions worth $30.5B, up 25% from $24.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
SG Americas Securities deployed $9.67B of net new capital in Q1 2025, opening 751 new positions and adding to 1,330 existing holdings. Its largest new stake was Biogen: 719,793 shares worth $98.5M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $409M trimmed.
- SG Americas Securities's largest Q1 2025 buy was Biogen: 719,793 shares worth $98.5M.
- SG Americas Securities added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $1.46B increase.
- SG Americas Securities's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $409M.
- SG Americas Securities fully exited iShares Ethereum Trust ETF in Q1 2025, selling an estimated $49.8M.
- SG Americas Securities's ten largest holdings make up 47% of its $30.5B portfolio in Q1 2025.
- SG Americas Securities opened 751 new positions and closed 418 in Q1 2025.
- SG Americas Securities's portfolio value rose 25% quarter-over-quarter to $30.5B.
Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.